This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

19 Nov 2010

Inovio Pharmaceuticals' HIV DNA Vaccine Achieves Strong T-Cell Immune Responses in Phase I Human Trial

Significant T-cell responses demonstrate potential of PENNVAX?-B HIV DNA vaccine delivered using electroporation.

Related News